📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies. (2020)

First Author: Sendama W

Attributed to: Optimising Innate Host Defence to Combat Antimicrobial Resistance funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.csbj.2020.11.054

PubMed Identifier: 33312454

Publication URI: http://europepmc.org/abstract/MED/33312454

Type: Journal Article/Review

Volume: 18

Parent Publication: Computational and structural biotechnology journal

ISSN: 2001-0370